Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copper Carbonate, X-cu(ii) Salt
1. Cupric Carbonate
2. Copper(ii) Carbonate
3. 1184-64-1
4. Copper Monocarbonate
5. Copper;carbonate
6. Copper Carbonate (1:1)
7. Carbonic Acid, Copper(2+) Salt (1:1)
8. Carbonic Acid, Copper Salt
9. 9aoa5f11gj
10. Cupromaag
11. 7492-68-4
12. Cupric Carbonate (1:1)
13. Copper Carbonate (cuco3)
14. Hsdb 258
15. Einecs 214-671-4
16. Unii-9aoa5f11gj
17. Cupriccarbonate
18. Copper (ii) Carbonate
19. Carbonic Acid,copper Salt
20. Cupric Carbonate, Aldrichcpr
21. Schembl29678
22. Copper (as Carbonate)
23. Dtxsid6034471
24. Cupric Carbonate [who-dd]
25. Copper(ii) Carbonate [hsdb]
26. Mfcd00051038
27. Ft-0624118
28. D78271
29. Q409630
| Molecular Weight | 123.55 g/mol |
|---|---|
| Molecular Formula | CCuO3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 122.914341 g/mol |
| Monoisotopic Mass | 122.914341 g/mol |
| Topological Polar Surface Area | 63.2 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 18.8 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
MEDICATION (VET): ANTHELMINTIC AID IN SHEEP
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 134
Rats were fed a diet contain basic cupric carbonate, at doses of 0, 70, 220, 670 and 2,000 ppm as cupric hydroxide and 12 months, the levels of copper in the blood and tissues were determined by atomic absorption analysis. At the same time, fluctuations in the levels of iron and zinc, which are essential elements, were determined in the tissues. Levels of copper, iron and zinc in blood were practically unchanged after feeding for 12 months at the highest dose, 2000 ppm. Copper in the liver increased markedly at doses of 670 and 2000 ppm from 1 month, and the level reached about 50 times that of the control group. The level of copper in the kidney significantly increased at larger doses than 670 ppm. Iron concentration in the kidney did not change at smaller doses than 220 ppm, but significantly decreased at higher doses than 670 ppm. The level of copper in the kidney increased only at the highest dose. /Basic cupric carbonate/
Fujita M; Nakazawa H; J Food Hyg Soc Jpn 26 (6): 617-23 (1985)
ABOUT THIS PAGE
A Copper Carbonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copper Carbonate, including repackagers and relabelers. The FDA regulates Copper Carbonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copper Carbonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Copper Carbonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Copper Carbonate supplier is an individual or a company that provides Copper Carbonate active pharmaceutical ingredient (API) or Copper Carbonate finished formulations upon request. The Copper Carbonate suppliers may include Copper Carbonate API manufacturers, exporters, distributors and traders.
click here to find a list of Copper Carbonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Copper Carbonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copper Carbonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copper Carbonate GMP manufacturer or Copper Carbonate GMP API supplier for your needs.
A Copper Carbonate CoA (Certificate of Analysis) is a formal document that attests to Copper Carbonate's compliance with Copper Carbonate specifications and serves as a tool for batch-level quality control.
Copper Carbonate CoA mostly includes findings from lab analyses of a specific batch. For each Copper Carbonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copper Carbonate may be tested according to a variety of international standards, such as European Pharmacopoeia (Copper Carbonate EP), Copper Carbonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copper Carbonate USP).
LOOKING FOR A SUPPLIER?
